122 related articles for article (PubMed ID: 11203252)
1. Good publication practice guideline for pharmaceutical companies.
Wager E; Tumas JA; Field EA; Glazer NB; Schulz G; Grossman L
Can J Gastroenterol; 2000 Oct; 14(9):749. PubMed ID: 11203252
[No Abstract] [Full Text] [Related]
2. "Good Publication Practice for Pharmaceutical Companies": where are we now?
Wager E
MedGenMed; 2005 Apr; 7(2):6. PubMed ID: 16369385
[TBL] [Abstract][Full Text] [Related]
3. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective.
Norris RA
Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261
[No Abstract] [Full Text] [Related]
4. Good publication practices for pharmaceutical companies: why we need another set of guidelines.
Wager E; Field EA; Grossman L
Curr Med Res Opin; 2003; 19(3):147-8. PubMed ID: 12814126
[No Abstract] [Full Text] [Related]
5. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
[TBL] [Abstract][Full Text] [Related]
6. Good practice for publishing the results of clinical trials.
Wager E
J Br Menopause Soc; 2005 Sep; 11(3):109-11. PubMed ID: 16157002
[TBL] [Abstract][Full Text] [Related]
7. Good publication practice for pharmaceutical companies.
Wager E; Field EA; Grossman L
Curr Med Res Opin; 2003; 19(3):149-54. PubMed ID: 12814125
[TBL] [Abstract][Full Text] [Related]
8. In the dark: drug companies should be forced to publish all the results of clinical trials.
Chalmers I
New Sci; 2004 Mar 6-12; 181(2437):19. PubMed ID: 15139350
[No Abstract] [Full Text] [Related]
9. [Research results should be freely accessible!-- Case reports demonstrate obstacles to contact with drug industry].
Eliasson M; Bergqvist D
Lakartidningen; 2001 Sep; 98(37):3913-6. PubMed ID: 11586830
[TBL] [Abstract][Full Text] [Related]
10. Registering clinical trials in India.
Bhatt A; Sewlikar S
Natl Med J India; 2006; 19(1):1-3. PubMed ID: 16570676
[No Abstract] [Full Text] [Related]
11. [Beliefs, hopes, misbeliefs (connection between the pharmaceutical industry and clinical research)].
Simon K
Orv Hetil; 2004 Jun; 145(24):1275-6. PubMed ID: 15264755
[No Abstract] [Full Text] [Related]
12. Depressing research.
Wager E
Lancet; 2004 Jun; 363(9426):2087-8. PubMed ID: 15207965
[No Abstract] [Full Text] [Related]
13. Comment on: Good publication practice guidelines for medical communications agencies: a MedComm perspective.
Snyder G; Graf C
Curr Med Res Opin; 2009 Jun; 25(6):1515; author reply 1515-6. PubMed ID: 19456282
[No Abstract] [Full Text] [Related]
14. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
Campbell MJ
Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
[No Abstract] [Full Text] [Related]
15. Pharmaceutical companies and ophthalmic research.
Liesegang TJ; Schachat AP; Albert DA
Ophthalmology; 2005 Mar; 112(3):363-5. PubMed ID: 15745760
[No Abstract] [Full Text] [Related]
16. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials.
Roehr B
BMJ; 2012 May; 344():e3767. PubMed ID: 22641830
[No Abstract] [Full Text] [Related]
17. The potential for bias in reporting of industry-sponsored clinical trials.
Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J
Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037
[TBL] [Abstract][Full Text] [Related]
18. Good publishing practice.
Knottnerus JA; Tugwell P
J Clin Epidemiol; 2012 Apr; 65(4):353-4. PubMed ID: 22360986
[No Abstract] [Full Text] [Related]
19. Sponsorship, authorship, and accountability.
Holmer AF
Ann Intern Med; 2002 Feb; 136(3):251-2; author reply 251-2. PubMed ID: 11827503
[No Abstract] [Full Text] [Related]
20. Control of data, authorship, and responsibility for clinical trials publications.
Freeman WR
Ophthalmology; 2005 Sep; 112(9):1485-6. PubMed ID: 16139664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
